Back
Summit Therapeutics Stock Price Chart
Invest in the Next Big AI Disruptor Today
Learn More
Sell
47
SMMT
Summit Therapeutics
Last Price:
18.62
Seasonality Move:
25.3%
7 Day Trial
ALL ACCESS PASS
$
7
AI Tech Innovator Poised for Strategic Buyouts Invest Now
Learn More- The current trend is moderately bearish and SMMT is experiencing slight selling pressure.
Summit Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.72 | Sell |
| 20-day SMA: | 22.52 | Sell |
| 50-day SMA: | 15.95 | Buy |
| 200-day SMA: | 7.71 | Buy |
| 8-day EMA: | 21.5 | Sell |
| 20-day EMA: | 21.04 | Sell |
| 50-day EMA: | 17.19 | Buy |
| 200-day EMA: | 9.52 | Buy |
Summit Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.5 | Buy |
| Relative Strength Index (14 RSI): | 48.63 | Sell |
| Chaikin Money Flow: | -1807634 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.88 - 26.24) | Sell |
| Bollinger Bands (100): | (5.26 - 17.92) | Buy |
Summit Therapeutics Technical Analysis
| Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 19 | 20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Summit Therapeutics Stock
Is Summit Therapeutics Stock a Buy?
- Summit Therapeutics share price is 19.54 while SMMT 8-day simple moving average is 21.72, which is a Sell signal.
- The stock price of SMMT is 19.54 while Summit Therapeutics 20-day SMA is 22.52, which makes it a Sell.
- Summit Therapeutics 50-day simple moving average is 15.95 while SMMT share price is 19.54, making it a Buy technically.
- SMMT stock price is 19.54 and Summit Therapeutics 200-day simple moving average is 7.71, creating a Buy signal.
SMMT Technical Analysis vs Fundamental Analysis
Sell
47
Summit Therapeutics (SMMT)
is a Sell
Is Summit Therapeutics a Buy or a Sell?
-
Summit Therapeutics stock is rated a Sell
The current Summit Therapeutics [SMMT] share price is $19.54. The Score for SMMT is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
Summit Therapeutics Stock Info
Market Cap:
14.36B
Price in USD:
19.54
Share Volume:
4.12M
Summit Therapeutics 52-Week Range
52-Week High:
33.89
52-Week Low:
1.64
Sell
47
Summit Therapeutics (SMMT)
is a Sell
Summit Therapeutics Share Price Forecast
-
What is the Summit Therapeutics stock price today?
The Summit Therapeutics stock price is 19.54 USD today. -
Will SMMT stock go up or go down?
Summit Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Summit Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Summit Therapeutics is overvalued.
Is Summit Therapeutics Stock a Buy?
- Summit Therapeutics share price is 19.54 while SMMT 8-day exponential moving average is 21.50, which is a Sell signal.
- The stock price of SMMT is 19.54 while Summit Therapeutics 20-day EMA is 21.04, which makes it a Sell.
- Summit Therapeutics 50-day exponential moving average is 17.19 while SMMT share price is 19.54, making it a Buy technically.
- SMMT stock price is 19.54 and Summit Therapeutics 200-day simple moving average is 9.52, creating a Buy signal.
Fundamental Analysis of Summit Therapeutics
Is Summit Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.32 per share, and a decrease next year of $0.03 per share.
Technical Analysis of Summit Therapeutics
Should I short Summit Therapeutics stock?
- SMMT Moving Average Covergence Divergence (MACD) indicator is 1.5, suggesting Summit Therapeutics is a Buy
- Summit Therapeutics Relative Strength Index (RSI) is 48.63, which suggest Summit Therapeutics is oversold
- The Bollinger Bands (25) for Summit Therapeutics is (14.88 - 26.24), which suggest Summit Therapeutics is a Buy
- The Bollinger Bands (100) for Summit Therapeutics is (5.26 - 17.92), which suggest Summit Therapeutics is a Buy
* Summit Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.